Some investors asked Huabang Health on an interactive platform. Your company has a wide range of channels for dermatology prescriptions. It is recommended to expand hair growth drugs with a high market ceiling. First, use the drugs in the guidelines, imitate minoxidil and finasteride, but change the dosage form. What is currently not on the market, such as oral sustained-release capsules or gels for external use; then invest in the development of a new type of innovative hair growth drug? Huabang Health replied that the company has not yet involved finasteride and minoxidil related products, but the field of hair growth is one of the company's concerns.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.